Avidity Biosciences Inc (RNA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -563.335 | -49.032 | -20.592 | -30.995 | -32.633 | -33.49 |
Return on Equity (%) | 54.541 | 46.455 | -36.83 | -34.322 | -36.268 | -39.342 |
Return on Invested Capital (%) | 2343.304 | -49.382 | -23.488 | -34.392 | -37.359 | -43.735 |
Operating Margin (%) | -2769.921 | -748.038 | -650.449 | -1265.376 | -1886.329 | -2219.874 |
Net Profit Margin (%) | -2959.367 | -1066.58 | -653.529 | -1265.376 | -1886.329 | -2219.874 |
Book Value Per Share | N/A | 23.206 | 8.151 | 7.987 | 8.286 | 6.758 |
Earnings Per Share | N/A | -8.275 | -1.181 | -2.471 | -2.494 | -2.864 |
Cash Per Share | N/A | 31.642 | 8.557 | 6.71 | 4.879 | 2.498 |
Working Capital Per Share | N/A | 28.585 | 8.44 | 7.989 | 8.185 | 7.161 |
Operating Profit Per Share | N/A | 0.776 | 0.181 | 0.195 | 0.132 | 0.129 |
EBIT Per Share | N/A | -8.275 | -1.181 | -2.471 | -2.494 | -2.864 |
EBITDA Per Share | N/A | -8.275 | -1.181 | -2.471 | -2.494 | -2.864 |
Free Cash Flow Per Share | N/A | -8.313 | -1.161 | -2.406 | -2.473 | -2.835 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | N/A | 2,99M | 37,57M | 47,75M | 69,77M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 69,77M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -2346.35 | N/A | N/A | N/A | -1943.41 | N/A | N/A |
Net Profit Margin (%) | N/A | -2346.35 | N/A | N/A | N/A | -1943.41 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 3,91B |
Ratio cours/bénéfice | -18,44 |
Ratio prix/ventes | 409,49 |
Ratio prix/liquidités | 21,14 |
Ratio prix/valeur comptable | 7,81 |
Rendement de dividende | - |
Actions en circulation | 119,31M |
Volume moyen (1 semaine) | 1,42M |
Volume moyen (1 mois) | 1,14M |
Variation sur 52 semaines | 276,63% |
Plus haut sur 52 semaines | 56,00 |
Plus bas sur 52 semaines | 8,37 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales